전엑솜 시퀀스 시장 규모, 점유율, 성장 분석 : 제품별, 기술별, 워크플로우별, 용도별, 최종 용도별, 지역별 - 산업 예측)2025-2032년)
Whole Exome Sequencing Market Size, Share, Growth Analysis, By Product (Instruments, Consumables), By Technology (Sequencing by Synthesis, ION Semiconductor Sequencing), By Workflow, By Application, By End-use, By Region - Industry Forecast 2025-2032
상품코드:1630647
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2025년 01월
페이지 정보:영문 157 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 전엑솜 시퀀스 시장 규모는 2023년에 4억 9,688만 달러에 달하며, 2024년 5억 8,334만 달러에서 2032년에는 21억 506만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 17.4%로 성장할 전망입니다.
전체 엑솜 시퀀싱 시장은 유전성 질환 및 만성질환의 조기 및 정확한 검출을 촉진하는 기술 발전으로 인해 강력한 성장세를 보이고 있습니다. 연구 및 진단 분야의 새로운 용도는 비용 절감과 함께 맞춤형 의료 솔루션에 대한 수요를 크게 증가시키고 있습니다. 의료 전문가들은 현재 전체 엑솜 시퀀싱을 활용하여 유전적 변이를 식별하고, 환자 개개인에 맞는 치료법을 개발하여 임상 결과를 개선하고 있습니다. BGI Genomics와 중국의 의료 서비스 프로바이더와 BGI Genomics의 제휴와 같은 협업은 이러한 서비스가 점점 더 쉽게 이용할 수 있게된 것을 증명합니다. 특히 Natera의 FDA 지정 혁신 기기인 Signatera와 같은 혁신적인 기술은 암 진단 및 모니터링에 있으며, 엑솜 시퀀싱의 혁신적 잠재력을 보여주고 있습니다. 개인맞춤형 의료가 주도하는 가운데, 시장은 새로운 진단법과 기술로 지속적으로 확대될 준비가 되어 있습니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요의 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
전엑솜 시퀀스 시장 규모 : 제품별
시장 개요
기기
소모품
시스템
키트
서비스
전엑솜 시퀀스 시장 규모 : 기술별
시장 개요
합성에 의한 시퀀스
이온 반도체 시퀀스
기타
전엑솜 시퀀스 시장 규모 : 워크플로우별
시장 개요
프리시퀀스
시퀀스
데이터 분석
전엑솜 시퀀스 시장 규모 : 용도별
시장 개요
임상 진단
의약품 발견과 개발
맞춤형 의료
농업과 동물 조사
기타
전엑솜 시퀀스 시장 규모 : 최종 용도별
시장 개요
학술연구기관
병원·클리닉
제약·바이오테크놀러지 기업
기타
전엑솜 시퀀스 시장 규모
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
시장의 최근 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
회사 개요
제품 포트폴리오 분석
부문별 점유율 분석
매출의 전년대비 비교(2022-2024년)
주요 기업 개요
Illumina, Inc.(USA)
Thermo Fisher Scientific, Inc.(USA)
Agilent Technologies, Inc.(USA)
Pacific Biosciences of California, Inc.(PacBio)(USA)
Oxford Nanopore Technologies plc.(UK)
BGI Genomics Co., Ltd.(China)
Eurofins Scientific SE(Luxembourg)
Bio-Rad Laboratories, Inc.(USA)
Novogene Co., Ltd.(China)
Azenta, Inc.(formerly GENEWIZ)(USA)
CD Genomics(USA)
Psomagen, Inc.(South Korea)
F. Hoffmann-La Roche AG(Switzerland)
10x Genomics, Inc.(USA)
Bionano Genomics, Inc.(USA)
Dante Labs(Italy)
MGI Tech Co., Ltd.(China)
GeneDx Holdings Corp.(USA)
Helix OpCo, LLC(USA)
결론과 권장사항
KSA
영문 목차
영문목차
Global Whole Exome Sequencing Market size was valued at USD 496.88 million in 2023 and is poised to grow from USD 583.34 million in 2024 to USD 2105.06 million by 2032, growing at a CAGR of 17.4% during the forecast period (2025-2032).
The market for whole exome sequencing is experiencing robust growth driven by advancements in technology that facilitate early and accurate detection of genetic and chronic diseases. New applications in research and diagnostics, coupled with decreasing costs, have significantly increased demand for personalized medical solutions. Medical professionals now leverage whole exome sequencing to identify genetic variations and tailor treatments to individual patients, enhancing clinical outcomes. Collaborations, such as the partnership between a Chinese healthcare provider and BGI Genomics, underscore the rising accessibility of these services. Notably, innovations like Natera's FDA-designated breakthrough device, Signatera, exemplify the transformative potential of exome sequencing in cancer diagnosis and monitoring. As personalized medicine gains traction, the market is poised for continued expansion with emerging diagnostics and technologies.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Whole Exome Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Whole Exome Sequencing Market Segmental Analysis
Global Whole Exome Sequencing Market is segmented by Product, Technology, Workflow, Application, End-use and region. Based on Product, the market is segmented into Instruments, Consumables, System, Kits and Services. Based on Technology, the market is segmented into Sequencing by Synthesis, ION Semiconductor Sequencing and Others. Based on Workflow, the market is segmented into Pre-Sequencing, Sequencing and Data Analysis. Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development, Personalized Medicines, Agriculture and Animal Research and Others. Based on End-use, the market is segmented into Academic And Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Whole Exome Sequencing Market
A key factor contributing to the expansion of the global whole exome sequencing market is the rising demand for personalized medicine. By analyzing an individual's entire exome, healthcare providers can tailor treatment plans that align with the patient's specific genetic profile and risk of disease. This bespoke approach not only enhances the efficacy of therapies but also promotes better patient outcomes. The continued advancements in sequencing technologies and data analysis capabilities have made whole exome sequencing increasingly accessible and cost-effective, thus encouraging its implementation in clinical environments. As the emphasis on personalized healthcare continues to grow, so does the demand for whole exome sequencing, shaping the future landscape of medical treatment.
Restraints in the Global Whole Exome Sequencing Market
A notable constraint impacting the global whole exome sequencing market is the challenges tied to data complexity and interpretation. The considerable volume of genomic data produced presents significant difficulties in analysis, necessitating extensive expertise and time. Ensuring that the results are both accurate and reliable is essential for making sound medical decisions. The reliance on advanced bioinformatics tools and qualified personnel for effective data handling and interpretation limits the broader adoption of whole exome sequencing. Consequently, this factor restricts its accessibility and feasibility in various healthcare environments, hindering the implementation of this innovative technology.
Market Trends of the Global Whole Exome Sequencing Market
The Global Whole Exome Sequencing market is witnessing a significant trend driven by the integration of artificial intelligence (AI) and machine learning (ML) algorithms into data analysis and interpretation processes. This innovative approach is transforming how vast amounts of genomic data generated through whole exome sequencing are processed, enabling more efficient identification of genetic variations and disease associations. By automating data handling, AI and ML improve accuracy and efficiency in genomic analysis, thus facilitating faster, precise diagnoses and personalized treatment strategies. As these technologies continue to evolve, they are set to revolutionize genomic medicine, underscoring their critical role in shaping the future of healthcare.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Global Whole Exome Sequencing Market Size by Product & CAGR (2025-2032)
Market Overview
Instruments
Consumables
System
Kits
Services
Global Whole Exome Sequencing Market Size by Technology & CAGR (2025-2032)
Market Overview
Sequencing by Synthesis
ION Semiconductor Sequencing
Others
Global Whole Exome Sequencing Market Size by Workflow & CAGR (2025-2032)
Market Overview
Pre-Sequencing
Sequencing
Data Analysis
Global Whole Exome Sequencing Market Size by Application & CAGR (2025-2032)
Market Overview
Clinical Diagnostics
Drug Discovery & Development
Personalized Medicines
Agriculture and Animal Research
Others
Global Whole Exome Sequencing Market Size by End-use & CAGR (2025-2032)
Market Overview
Academic And Research Institutes
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others
Global Whole Exome Sequencing Market Size & CAGR (2025-2032)
North America (Product, Technology, Workflow, Application, End-use)
US
Canada
Europe (Product, Technology, Workflow, Application, End-use)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Product, Technology, Workflow, Application, End-use)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Product, Technology, Workflow, Application, End-use)
Brazil
Rest of Latin America
Middle East & Africa (Product, Technology, Workflow, Application, End-use)
GCC Countries
South Africa
Rest of Middle East & Africa
Competitive Intelligence
Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
Company Details
Product Portfolio Analysis
Company's Segmental Share Analysis
Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
Illumina, Inc. (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Thermo Fisher Scientific, Inc. (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Agilent Technologies, Inc. (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Pacific Biosciences of California, Inc. (PacBio) (USA)
